ArticleMolecular medicine reports2017

Oncogenic miR‑132 sustains proliferation and self‑renewal potential by inhibition of polypyrimidine tract‑binding protein 2 in glioblastoma cells.

Silong Lou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.